Replies to post #63759 on THE PARADIGM SHIFT

[novicetrader]

CTIC..next important event this monday,whether it gets 'priority review' by FDA or not.
Aug. 24-U.S. Food and Drug Administration's responds to Cell Therapeutics' priority review request for pixantrone as a treatment for non-Hodgkin's lymphoma.